Inventor · disambiguated record
David Juergen Wustrow
Also filed as: WUSTROW DAVID · WUSTROW DAVID J · WUSTROW DAVID JUERGEN
72 granted patents·48 pending applications·574 citations·filing 1990–2024
99Inventor score
Top patents by PatentIndex Score
120 records- 0195US6642398B2Mono-and disubstituted 3-propyl gamma-aminobutyric acidsWARNER LAMBERT CO·Filed 2002·Granted Nov 4, 2003·45 cites·28 claims
- 0294US10683280B2Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2019·Granted Jun 16, 2020·8 cites·22 claims
- 0394US8344028B2Gamma-amino-butyric acid derivatives as GABAB receptor ligandsXENOPORT INC·Filed 2010·Granted Jan 1, 2013·43 cites·28 claims
- 0494US7381747B2Alpha 2 delta ligands for post-traumatic stress disorderWARNER LAMBERT CO·Filed 2006·Granted Jun 3, 2008·8 cites·2 claims
- 0593US11384064B2Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2020·Granted Jul 12, 2022·3 cites·28 claims
- 0692US11192879B2Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2020·Granted Dec 7, 2021·3 cites·28 claims
- 0792US8952006B2Morpholinoalkyl fumarate compounds, pharmaceutical compositions, and methods of useXENOPORT INC·Filed 2013·Granted Feb 10, 2015·15 cites·29 claims
- 0891US10246462B2Chemokine receptor modulators and uses thereofFLX BIO INC·Filed 2017·Granted Apr 2, 2019·10 cites·77 claims
- 0990US10179787B2Chemokine receptor modulators and uses thereofFLX BIO INC·Filed 2017·Granted Jan 15, 2019·5 cites·38 claims
- 1087US10604526B2Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2018·Granted Mar 31, 2020·2 cites·25 claims
- 1187US7122678B2Cyclic amino acids and derivatives thereof useful as pharmaceutical agentsWARNER LAMBERT CO·Filed 2005·Granted Oct 17, 2006·8 cites·1 claims
- 1286US9844554B2Prodrugs of metopimazineNEUROGASTRX INC·Filed 2015·Granted Dec 19, 2017·4 cites·20 claims
- 1385US12428393B2Methods of making trans isomeric forms of G protein-coupled receptor modulatorsRAPT THERAPEUTICS INC·Filed 2022·Granted Sep 30, 2025·1 cites·13 claims
- 1485US10716760B2Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofXENOPORT INC·Filed 2016·Granted Jul 21, 2020·2 cites·18 claims
- 1585US9062026B2Fused pyrimidines and substituted quinazolines as inhibitors of p97CLEAVE BIOSCIENCES INC·Filed 2013·Granted Jun 23, 2015·6 cites·3 claims
- 1685US8431593B2Heteroaryl amide derivativesHUTCHISON ALAN J·Filed 2007·Granted Apr 30, 2013·13 cites·18 claims
- 1783US7138542B2Method of treating tinnitusWARNER LAMBERT CO·Filed 2005·Granted Nov 21, 2006·2 cites·2 claims
- 1883US2025059167A1Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1982US10940117B2Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofARBOR PHARMACEUTICALS LLC·Filed 2020·Granted Mar 9, 2021·1 cites·12 claims
- 2081US11046699B2Pyrazolo-pyrimidin-amino-cycloalkyl compounds and their therapeutic usesRAPT THERAPEUTICS INC·Filed 2019·Granted Jun 29, 2021·3 cites·46 claims
- 2181US9828363B2Fused pyrimidines as inhibitors of P97 complexCLEAVE BIOSCIENCES INC·Filed 2015·Granted Nov 28, 2017·3 cites·20 claims
- 2281US6809119B2Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseasesWARNER LAMBERT CO·Filed 2002·Granted Oct 26, 2004·15 cites·7 claims
- 2381US5532226ATrifluoromethybenzylphosphonates useful in treating osteoporosisORTHO PHARMA CORP·Filed 1993·Granted Jul 2, 1996·35 cites·12 claims
- 2481US2024199620A1Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2579US6245801B1Branched alkyl pyrrolidine-3-carboxylic acidsWARNER LAMBERT CO·Filed 1999·Granted Jun 12, 2001·48 cites·16 claims
- 2679US2024024249A1Oral dosage forms having a high loading of a methyl hydrogen fumarate prodrugARBOR PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 2778US11084829B2Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2019·Granted Aug 10, 2021·2 cites·55 claims
- 2877US12098139B2Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2022·Granted Sep 24, 2024·0 cites·24 claims
- 2977US7164034B2Alpha2delta ligands for fibromyalgia and other disordersPFIZER·Filed 2003·Granted Jan 16, 2007·7 cites·5 claims
- 3077US2020087272A1Treatment of multiple sclerosis and psoriasis using prodrugs of methyl hydrogen fumarateARBOR PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
- 3176US2021179573A1Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen FumarateARBOR PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 3275US7026505B2Method of treating tinnitusWARNER LAMBERT CO·Filed 2003·Granted Apr 11, 2006·4 cites·2 claims
- 3374US10010554B2Fused pyrimidines as inhibitors of P97 complexCLEAVE BIOSCIENCES INC·Filed 2016·Granted Jul 3, 2018·1 cites·25 claims
- 3473US10722514B2Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereofFLX BIO INC·Filed 2018·Granted Jul 28, 2020·2 cites·33 claims
- 3573US9868722B2Monocyclic pyrimidine/pyridine compounds as inhibitors of P97 complexCLEAVE BIOSCIENCES INC·Filed 2014·Granted Jan 16, 2018·1 cites·12 claims
- 3673US6436974B1Amino heterocycles useful as pharmaceutical agentsWARNER LAMBERT CO·Filed 2000·Granted Aug 20, 2002·6 cites·19 claims
- 3773US2024317768A1Crystalline forms of c-c chemokine receptor type 4 antagonist and uses thereofRAPT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3872US7432299B2Method of treatment for sexual dysfunctionPFIZER·Filed 2003·Granted Oct 7, 2008·4 cites·12 claims
- 3972US7189747B2Method of treating noninflammatory cartilage damageWARNER LAMBERT CO·Filed 2003·Granted Mar 13, 2007·5 cites·4 claims
- 4072US6620829B2Method of treating noninflammatory cartilage damageWARNER LAMBERT CO·Filed 2001·Granted Sep 16, 2003·3 cites·6 claims
- 4172US5300687ATrifluoromethylbenzylphosphonates useful in treating osteoporosisORTHO PHARMA CORP·Filed 1991·Granted Apr 5, 1994·22 cites·2 claims
- 4272US5089497ASubstituted piperazines as central nervous system agentsWARNER LAMBERT CO·Filed 1990·Granted Feb 18, 1992·14 cites·7 claims
- 4371US12240837B2Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2023·Granted Mar 4, 2025·0 cites·42 claims
- 4471US9475824B2Fused pyrimidines as inhibitors of p97 complexCLEAVE BIOSCIENCES INC·Filed 2013·Granted Oct 25, 2016·1 cites·14 claims
- 4571US7064147B2Amino acids with affinity for the α-2-delta-proteinWARNER LAMBERT CO·Filed 2003·Granted Jun 20, 2006·4 cites·8 claims
- 4671US5118691ASubstituted tetrahydropyridines as central nervous system agentsWARNER LAMBERT CO·Filed 1991·Granted Jun 2, 1992·13 cites·6 claims
- 4770US6632831B2Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseasesPFIZER·Filed 2002·Granted Oct 14, 2003·5 cites·15 claims
- 4870US2021145755A1Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofARBOR PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 4969US8377956B2Use of (3R)-4-{[(1S)-2-methyl-1-(2-methylpropanoyloxy)propoxy]carbonylamino}-3-(4-chlorophenyl) butanoic acid for treating urinary incontinenceXENOPORT INC·Filed 2011·Granted Feb 19, 2013·1 cites·20 claims
- 5069US5045550ASubstituted tetrahydropyridines as central nervous system agentsWARNER LAMBERT CO·Filed 1990·Granted Sep 3, 1991·11 cites·6 claims
Showing the top 50 of 120 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →